Generic-Drug Co. wants to reconsider “double patenting.”

By Andrew Karpan (September 30, 2024, 6:01 p.m. EDT) — An Indian generic drug maker wants the full Federal Court to take a closer look at the issue of “double patenting,” pointing out that a recent panel made a flawed decision breathed new life into pharmaceutical patents for a drug against diarrhea…

Law360 is there, so you are too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments, so you can act quickly and confidently. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features like

• Daily newsletters
• Expert analysis
• Mobile app
• Advanced search
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.